Literature DB >> 9187511

Selective protein arylation and acetaminophen-induced hepatotoxicity.

S D Cohen1, E A Khairallah.   

Abstract

More than 20 years have passed since the early reports of acute hepatotoxicity with APAP overdose. During that period investigative research to discover the "mechanism" underlying the toxicity has been conducted in many species and strains of intact animals as well as in a variety of in vitro and culture systems. Such work has clarified the primary role of biotransformation and the protective role of GSH. Understanding the former provides explanations for the toxic interactions which may occur with alcohol or other xenobiotics, while understanding of the latter led to the development of antidotes for the treatment of acute poisoning. Acetaminophen (APAP)-induced hepatotoxicity: roles for protein arylation. Initiating events in toxicity require biotransformation of APAP to NAPQI followed by arylation of several important proteins with subsequent alteration of protein structure and function. The immediate consequence of the alterations is detectable in several organelles and these may represent multiple initiating events which are depicted as acting in concert to cause cell injury (large arrowheads). Arylation of cytosolic 58-ABP with subsequent translocation to the nucleus is depicted as a possible signaling mechanism for determining outcome at the cell or organ level (within dotted boundary). For simplicity NAPQI's potentials for oxidizing protein sulfhydryls and direct binding to DNA have been omitted. Significant light has also been shed on the biochemical and cellular events which accompany APAP-induced hepatotoxicity. However, such studies have not identified a unique mechanism of toxicity that is universally accepted. The recent identification of several protein targets which become arylated during toxicity--along with the findings that arylation of some of those target proteins results in loss of protein function--demonstrates that covalent binding does, indeed, have biological consequences and is not merely an indicator of the fleeting presence of reactive electrophiles. These observations further suggest that multiple independent insults to the cell may be involved in toxicity. it is now apparent that the concept of a multistage process that involves both initiation and progression events is appropriate for APAP toxicity, and it is unlikely that a unique initiating event will ever be identified. In light of recent findings it is more likely that a number of such cellular events occur very early after toxic overdosage, and that they collectively set in motion and perpetuate the biochemical, cellular, and molecular processes which will determine outcome. The importance of 58-ABP arylation with early, apparently selective, translocation to the nucleus remains to be elucidated. To date there is nothing to suggest that this represents an initiating event in toxicity. rather it is plausible that the translocation may play a role in signaling electrophile presence and in calling for cellular defense against electrophile insult. This is reflected in the hypothetical model presented in Fig. 3. Critical experimental testing of this model will advance our understanding of the cellular and molecular responses to toxic electrophile insult.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187511     DOI: 10.3109/03602539709037573

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  39 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  JS-K has potent anti-angiogenic activity in vitro and inhibits tumour angiogenesis in a multiple myeloma model in vivo.

Authors:  Tanyel Kiziltepe; Kenneth C Anderson; Jeffery L Kutok; Lee Jia; Kenneth M Boucher; Joseph E Saavedra; Larry K Keefer; Paul J Shami
Journal:  J Pharm Pharmacol       Date:  2010-01       Impact factor: 3.765

3.  Nrf2-mediated liver protection by sauchinone, an antioxidant lignan, from acetaminophen toxicity through the PKCδ-GSK3β pathway.

Authors:  Hee Yeon Kay; Young Woo Kim; Da Hye Ryu; Sang Hyun Sung; Se Jin Hwang; Sang Geon Kim
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

4.  The hepatic stem cell niche: identification by label-retaining cell assay.

Authors:  Reiichiro Kuwahara; Alexander V Kofman; Charles S Landis; E Scott Swenson; Els Barendswaard; Neil D Theise
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

5.  TRPM2 channels mediate acetaminophen-induced liver damage.

Authors:  Ehsan Kheradpezhouh; Linlin Ma; Arthur Morphett; Greg J Barritt; Grigori Y Rychkov
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

6.  Renal function and arterial blood pressure alterations after exposure to acetaminophen with a potential role of Nigella sativa oil in adult male rats.

Authors:  Omyma Galal Ahmed; Nashwa Aly Abd El-Mottaleb
Journal:  J Physiol Biochem       Date:  2012-06-23       Impact factor: 4.158

7.  Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice.

Authors:  Hong-Min Ni; Mitchell R McGill; Xiaojuan Chao; Kuo Du; Jessica A Williams; Yuchao Xie; Hartmut Jaeschke; Wen-Xing Ding
Journal:  J Hepatol       Date:  2016-05-02       Impact factor: 25.083

8.  Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury.

Authors:  Mohamed A Abdelmegeed; Sehwan Jang; Atrayee Banerjee; James P Hardwick; Byoung-Joon Song
Journal:  Free Radic Biol Med       Date:  2013-02-27       Impact factor: 7.376

9.  Mechanism of protection by metallothionein against acetaminophen hepatotoxicity.

Authors:  Chieko Saito; Hui-Min Yan; Antonio Artigues; Maria T Villar; Anwar Farhood; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2009-10-14       Impact factor: 4.219

10.  Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity.

Authors:  Runkuan Yang; Keita Miki; Xin He; Meaghan E Killeen; Mitchell P Fink
Journal:  Crit Care       Date:  2009-04-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.